Literature DB >> 18822831

Medications for adolescents with attention-deficit/hyperactivity disorder.

Earl J Soileau1.   

Abstract

ADHD is recognized as a neurologic condition rather than just bad behavior. Medical treatment has been recognized as very helpful. Risks of untreated ADHD are substantial. Every life area is negatively affected including school performance, drug abuse and dependence risk, driving performance, sexually transmitted diseases, unwanted pregnancy and family cohesiveness to mention some of them. Frequent misinformation in the popular media causes apprehension about medical treatment. Even after almost 60 years stimulants remain the mainstay in treatment of ADHD. Newer release systems have produced longer acting and smoother acting medication. Side effects have always been brief and mild however, newer forms cause fewer side effects than older preparations and cover symptoms for more of the waking hours of each day. Although studies in adolescents are less numerous than in children the literature standard supports the safety and efficacy of stimulants in adolescents. In addition there are non-stimulant medications that have shown efficacy in adolescents. There are now a greater number of medications and more effective medications than ever before. Clinical pearls in medication management are shared in practical terms so that these newer treatments can be used to help those affected with ADHD more effectively than ever before.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822831

Source DB:  PubMed          Journal:  Adolesc Med State Art Rev        ISSN: 1934-4287


  4 in total

1.  Effects of sub-chronic methylphenidate on risk-taking and sociability in zebrafish (Danio rerio).

Authors:  Rebecca G Brenner; Anthony N Oliveri; Walter Sinnott-Armstrong; Edward D Levin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-02-06       Impact factor: 3.000

2.  Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish.

Authors:  Edward D Levin; Damiyon Sledge; Stephanie Roach; Ann Petro; Susan Donerly; Elwood Linney
Journal:  Neurotoxicol Teratol       Date:  2011-07-07       Impact factor: 3.763

Review 3.  Modelling ADHD-Like Phenotypes in Zebrafish.

Authors:  Barbara D Fontana; William H J Norton; Matthew O Parker
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Psychopharmacology of ADHD in pediatrics: current advances and issues.

Authors:  Donald E Greydanus; Ahsan Nazeer; Dilip R Patel
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.